IBEX Limited (NASDAQ:IBEX) Sees Significant Increase in Short Interest

IBEX Limited (NASDAQ:IBEX) was the recipient of a significant growth in short interest in February. As of February 15th, there was short interest totalling 141,700 shares, a growth of 29.9% from the January 31st total of 109,100 shares. Based on an average daily volume of 190,300 shares, the short-interest ratio is currently 0.7 days. Currently, 1.3% of the company’s shares are sold short.

IBEX Stock Down 1.5 %

NASDAQ IBEX traded down $0.38 during trading on Tuesday, hitting $24.52. The stock had a trading volume of 160,097 shares, compared to its average volume of 217,732. IBEX has a 12 month low of $13.00 and a 12 month high of $27.83. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.44 and a current ratio of 1.44. The company’s 50-day moving average price is $23.26 and its two-hundred day moving average price is $20.54. The company has a market capitalization of $323.47 million, a PE ratio of 11.51 and a beta of 0.78.

IBEX (NASDAQ:IBEX) last announced its quarterly earnings data on Thursday, February 6th. The company reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.49 by $0.02. IBEX had a net margin of 7.08% and a return on equity of 25.29%.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on IBEX shares. Royal Bank of Canada increased their price objective on shares of IBEX from $21.00 to $24.00 and gave the stock a “sector perform” rating in a research report on Friday, February 7th. Robert W. Baird increased their target price on IBEX from $23.00 to $26.00 and gave the stock an “outperform” rating in a report on Friday, November 8th.

Insider Buying and Selling at IBEX

In other IBEX news, major shareholder Gem G.P. L.P. Pinebridge II sold 82,572 shares of the business’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $20.20, for a total value of $1,667,954.40. Following the completion of the transaction, the insider now directly owns 1,421,547 shares of the company’s stock, valued at approximately $28,715,249.40. The trade was a 5.49 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Shuja Keen sold 17,000 shares of the firm’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $20.27, for a total value of $344,590.00. Following the sale, the director now directly owns 71,110 shares in the company, valued at approximately $1,441,399.70. This represents a 19.29 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 326,719 shares of company stock valued at $7,547,658. Corporate insiders own 6.72% of the company’s stock.

Hedge Funds Weigh In On IBEX

Several hedge funds have recently modified their holdings of IBEX. JPMorgan Chase & Co. raised its holdings in IBEX by 386.9% during the third quarter. JPMorgan Chase & Co. now owns 19,345 shares of the company’s stock worth $387,000 after acquiring an additional 15,372 shares in the last quarter. Sanctuary Advisors LLC bought a new stake in shares of IBEX during the 4th quarter worth approximately $1,411,000. Jane Street Group LLC boosted its holdings in shares of IBEX by 114.6% in the 3rd quarter. Jane Street Group LLC now owns 29,960 shares of the company’s stock valued at $599,000 after buying an additional 15,999 shares during the last quarter. Barclays PLC increased its holdings in IBEX by 95.2% during the third quarter. Barclays PLC now owns 20,636 shares of the company’s stock worth $412,000 after buying an additional 10,062 shares during the last quarter. Finally, Ritholtz Wealth Management increased its holdings in IBEX by 76.9% during the fourth quarter. Ritholtz Wealth Management now owns 32,859 shares of the company’s stock worth $706,000 after buying an additional 14,279 shares during the last quarter. Institutional investors own 81.24% of the company’s stock.

IBEX Company Profile

IBEX Limited provides end-to-end technology-enabled customer lifecycle experience solutions in the United States and internationally. The company products and services portfolio includes ibex Connect, that offers customer service, technical support, revenue generation, and other revenue generation outsourced back-office services through the CX model, which integrates voice, email, chat, SMS, social media, and other communication applications; ibex Digital, a customer acquisition solution that comprises digital marketing, e-commerce technology, and platform solutions; and ibex CX, a customer experience solution, which provides a suite of proprietary software tools to measure, monitor, and manage its clients' customer experience.